St Mary's University College   Report issue

Academic/Hospital
Founded: Belfast United Kingdom (1900)

Organization Overview

First Clinical Trial
2018
NCT03668548
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Mark Glaister | St Mary's University College

Active Ingredients

Drugs in Other Trials (5)

acai polyphenolics (1 trial)

caffeine (1 trial)

curcumin (1 trial)

leucine (1 trial)

phosphatidylserine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 5
  • # of Trial APIs: 5